Sector: Healthcare | Industry: Pharmaceuticals |
See Regulatory Filings on SEDAR |
Company Contact | |
Address: | 8223 Roper Road EDMONTON AB T6E 6S4 |
Tel: | N/A |
Website: | www.radientinc.com |
IR: | See website |
Key People | ||
Harry Kaura President, Chief Executive Officer, Director | Prakash Hariharan Chief Financial Officer | Steven Joseph Splinter Chief Technology Officer, Corporate Secretary, Director |
Business Overview |
Radient Technologies Inc. is a Canada-based manufacturer of cannabis derivatives, formulations and products. The Company's principal activities are research, development and commercialization of technology for the extraction, isolation and purification of soluble products from a range of materials using microwave technology. The Company is focused on the formulation, manufacturing and launching of cannabis products. It develops specialty products that contains a range of cannabinoid and terpene profiles. It also operates a scientific and product testing laboratory that offers solutions to the cannabis and wellness spaces. Its extraction platform extracts cannabinoids from cannabis and hemp biomass. Its cannabis formulations include tinctures, topicals, sub-lingual sprays, standardized oils, stable water soluble and water dispersible powders and solid powders. Its cannabinoid-based ingredients are formulated for use in food and beverage products, personal care products and others. |
Financial Overview |
For the nine months ended 31 December 2021, Radient Technologies Inc revenues increased 75% to C$3.4M. Net loss decreased 66% to C$6.8M. Revenues reflect Manufactured products increase of 80% to C$3.4M. Lower net loss reflects Impairment of inventories decrease from C$6.6M (expense) to C$0K, General and administrative decrease of 43% to C$2M (expense), Interest on short-term borrowings decrease of 65% to C$332K (expense). |
Employees: | 33 as of Mar 31, 2020 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $27.26M as of Dec 31, 2021 |
Annual revenue (TTM): | $3.96M as of Dec 31, 2021 |
EBITDA (TTM): | -$5.97M as of Dec 31, 2021 |
Net annual income (TTM): | -$29.05M as of Dec 31, 2021 |
Free cash flow (TTM): | -$1.08M as of Dec 31, 2021 |
Net Debt Last Fiscal Year: | $12.07M as of Dec 31, 2021 |
Shares outstanding: | 530,868,021 as of Feb 4, 2022 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |